Kowichi Jimbow
#167,101
Most Influential Person Now
Kowichi Jimbow's AcademicInfluence.com Rankings
Kowichi Jimbowchemistry Degrees
Chemistry
#5003
World Rank
#6104
Historical Rank
Organic Chemistry
#837
World Rank
#937
Historical Rank
Kowichi Jimbowbiology Degrees
Biology
#13592
World Rank
#17146
Historical Rank
Molecular Biology
#2315
World Rank
#2350
Historical Rank
Biochemistry
#2393
World Rank
#2543
Historical Rank
Download Badge
Chemistry Biology
Kowichi Jimbow's Degrees
- PhD Biochemistry University of Tokyo
- Masters Chemistry Kyoto University
- Bachelors Chemistry Kyoto University
Why Is Kowichi Jimbow Influential?
(Suggest an Edit or Addition)Kowichi Jimbow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mechanism of depigmentation by hydroquinone. (1974) (256)
- Some aspects of melanin biology: 1950-1975. (1976) (245)
- Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase‐related protein in vitiligo (2001) (221)
- Induction of Suppressor of Cytokine Signaling-3 by Herpes Simplex Virus Type 1 Contributes to Inhibition of the Interferon Signaling Pathway (2004) (162)
- Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. (1975) (137)
- Quantitative analysis of eumelanin and pheomelanin in hair and melanomas. (1983) (135)
- Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. (2000) (114)
- Basic fibroblast growth factor reduces scar formation in acute incisional wounds (2007) (111)
- Mitotic activity in non-neoplastic melanocytes in vivo as determined by histochemical, autoradiographic, and electron microscope studies (1975) (111)
- Sunlight and Melanin Pigmentation (1976) (106)
- Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma. (1984) (102)
- Comparison of eumelanogenesis and pheomelanogenesis in retinal and follicular melanocytes; role of vesiculo-globular bodies in melanosome differentiation. (1979) (102)
- Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. (2001) (101)
- Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. (1973) (99)
- Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. (2004) (94)
- What's the use of generating melanin? (1999) (93)
- Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds (2004) (88)
- DUAL ROLE OF MELANINS AND MELANIN PRECURSORS AS PHOTOPROTECTIVE AND PHOTOTOXIC AGENTS: INHIBITION OF ULTRAVIOLET RADIATION‐INDUCED LIPID PEROXIDATION (1995) (84)
- Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway (2009) (79)
- New melanogenesis and photobiological processes in activation and proliferation of precursor melanocytes after UV-exposure: ultrastructural differentiation of precursor melanocytes from Langerhans cells. (1982) (78)
- Combined chemical and electron microscopic studies of pheomelanosomes in human red hair. (1983) (77)
- 4‐S‐Cysteaminylphenol‐loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma (2007) (76)
- N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. (1991) (73)
- Role of light in human skin color viariation. (1975) (73)
- Antitumor immunity by magnetic nanoparticle-mediated hyperthermia. (2014) (72)
- Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of α‐smooth muscle actin, leading to reduction of wound contraction (2007) (72)
- Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. (2004) (69)
- Diacylglycerol kinase α suppresses tumor necrosis factor-α-induced apoptosis of human melanoma cells through NF-κB activation (2007) (67)
- Changes in distribution pattern of cytoplasmic filaments in human melanocytes during ultraviolet-mediated melanin pigmentation. The role of the 100-Angstrom filaments in the elongation of melanocytic dendrites and in the movement and transfer of melanosomes (1975) (66)
- Promotion of tyrosinase folding in COS 7 cells by calnexin. (1999) (63)
- Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes. (1993) (63)
- Ultrastructural investigation of autophagocytosis of melanosomes and programmed death of melanocytes in White Leghorn feathers: a study of morphogenetic events leading to hypomelanosis. (1974) (60)
- Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. (1990) (59)
- Current update and trends in melanin pigmentation and melanin biology. (1995) (57)
- Cells containing Langerhans granules in human lymph nodes of dermatopathic lymphadenopathy. (1969) (56)
- Intracellular vesicular trafficking of tyrosinase gene family protein in eu- and pheomelanosome biogenesis. (2000) (55)
- Dose‐dependent induction of IL‐12 but not IL‐10 from human keratinocytes after exposure to ultraviolet light A (1998) (54)
- Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells. (2004) (51)
- Dysplastic melanocytic nevi contain high levels of pheomelanin: quantitative comparison of pheomelanin/eumelanin levels between normal skin, common nevi, and dysplastic nevi. (1991) (50)
- CONFLUENT AND RETICULATED PAPILLOMATOSIS: CLINICAL, LIGHT AND ELECTRON MICROSCOPIC STUDIES (1992) (48)
- Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study. (1997) (48)
- Langerhans' cells of the normal human pilosebaceous system. An electron microscopic investigation. (1969) (48)
- Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. (1993) (47)
- Characterization of a new melanosomal structural component--the vesiculoglobular body--by conventional transmission, high-voltage, and scanning electron microscopy. (1974) (45)
- Tyrosinase and tyrosinase-related protein 1 require Rab7 for their intracellular transport. (2002) (45)
- Development of squamous cell carcinoma by two high‐risk human papillomaviruses (HPVs), a novel HPV‐67 and HPV‐31 from bowenoid papulosis (2000) (45)
- Vitiligo. Therapeutic advances. (1998) (44)
- Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R (1995) (43)
- Electron microscopic identification of Langerhans cells in the dermal infiltrates of mycosis fungoides. (1982) (43)
- N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells. (2009) (43)
- CLINICAL CHARACTERISTICS OF SUBUNGUAL MELANOMAS IN JAPAN (1985) (42)
- What controls melanogenesis? (1998) (41)
- Characterization of biochemical properties of melanosomes for structural and functional differentiation: analysis of the compositions of lipids and proteins in melanosomes and their subfractions. (1982) (40)
- Pigmentary disorders in oriental skin. (1989) (40)
- Effect of ultraviolet on the distribution pattern of microfilaments and microtubules and on the nucleus in human melanocytes. (1973) (39)
- Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1. (1994) (39)
- Case Report of Darier Disease Localized to the Vulva in a 5‐Year‐Old Girl (1993) (38)
- Fine structural characterization of melanosomes in dysplastic nevi (1985) (38)
- Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma. (1986) (38)
- Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. (2003) (38)
- Experimental pigment donation in vivo. (1974) (37)
- High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma. (1994) (36)
- Topical therapies for melasma and disorders of hyperpigmentation (2001) (36)
- Malignant Melanoma in a Patient with Oculocutaneous Albinism (2000) (36)
- Growth Inhibition of Re-Challenge B16 Melanoma Transplant by Conjugates of Melanogenesis Substrate and Magnetite Nanoparticles as the Basis for Developing Melanoma-Targeted Chemo-Thermo-Immunotherapy (2009) (36)
- Melanoma‐targeted chemo‐thermo‐immuno (CTI)‐therapy using N‐propionyl‐4‐S‐cysteaminylphenol‐magnetite nanoparticles elicits CTL response via heat shock protein‐peptide complex release (2010) (34)
- Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds (2004) (34)
- The in vivo antimelanoma effect of 4‐S‐cysteaminylphenol and its N‐acetyl derivative (1990) (34)
- Identification of rab7 as a melanosome-associated protein involved in the intracellular transport of tyrosinase-related protein 1. (2001) (34)
- Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas. (1994) (34)
- Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa. (1984) (34)
- Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy. (1987) (33)
- Formation, Chemical Composition and Function of Melanin Pigments (1986) (31)
- Development of MoAB HMSA‐2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes (1987) (31)
- Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas. (1983) (31)
- Long‐Term Continuous versus Intermittent Cyclosporin: Therapy for Psoriasis (2003) (30)
- SIRT1 regulates lamellipodium extension and migration of melanoma cells. (2014) (30)
- Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs. (1999) (30)
- Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues. (1991) (29)
- The epidermal melanin unit in the pathophysiology of malignant melanoma. (1991) (29)
- Reduction of Serum Interleukin‐5 Levels Reflect Clinical Improvement in Patients with Atopic Dermatitis (2001) (29)
- Incorporation of sulfhydryl compounds into melanins in vitro. (1988) (29)
- Idiopathic acquired generalized anhidrosis due to occlusion of proximal coiled ducts (2004) (29)
- Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. (1994) (28)
- Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds. (1987) (26)
- Ultrastructural and cytochemical studies of melanogenesis in melanocytes of normal human hair matrix. (1971) (25)
- Characterization of Structural Properties for Morphological Differentiation of Melanosomes: II. Electron Microscopic and SDS-PAGE Comparison of Melanosomal Matrix Proteins in B16 and Harding Passey Melanomas (1982) (25)
- Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv. (2008) (25)
- Association of vesiculobullous eruptions with mycosis fungoides. (1987) (25)
- Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma (2020) (25)
- Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation. (2007) (25)
- Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol. (1998) (25)
- Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas. (1981) (24)
- Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases. (1992) (24)
- Immunohistochemical Detection of Melanoma-associated Antigens on Formalin-fixed, Paraffin-embedded Canine Tumors (1994) (23)
- Biological Monitoring of Solar UV Radiation at 17 Sites in Asia, Europe and South America from 1999 to 2004 (2006) (23)
- Acquired multiple pilosebaceous cysts on the face having the histopathological features of steatocystoma multiplex and eruptive vellus hair cysts (2004) (23)
- The nature and significance of macromelanosomes in pigmented skin lesions: Their morphological characteristics, specificity for their occurrence, and possible mechanisms for their formation (1982) (23)
- The chilblain-like eruption as a diagnostic clue to the blast crisis of chronic myelocytic leukemia. (2004) (23)
- Comparison of in vitro cytotoxicity of N‐acetyl and N‐propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity (2000) (23)
- Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues. (1990) (23)
- Inhibition of endogenous MHC class II‐restricted antigen presentation by tacrolimus (FK506) via FKBP51 (2007) (23)
- Benign mucous membrane pemphigoid. An unusual case with electron microscopic findings. (1972) (23)
- Regulatory factors of pheo- and eumelanogenesis in melanogenic compartments. (2008) (22)
- Tuberous sclerosis and guttate leukodermas. (1997) (22)
- Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4‐S‐cysteaminylphenol binds protein disulphide isomerase (1991) (22)
- Molecular Control of Melanogenesis in Malignant Melanoma: Functional Assessment of Tyrosinase and Lamp Gene Families by UV Exposure and Gene Co‐Transfection, and Cloning of a cDNA Encoding Calnexin, A Possible Melanogenesis “Chaperone” (1994) (22)
- Human skin color: Origin, variation and significance (1985) (21)
- Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade. (1996) (21)
- Heterogeneity of cutaneous T‐cell lymphoma. Phenotypic and ultrastructural characterization of four unusual cases (1985) (21)
- Downregulation of CXCR‐2 but not CXCR‐1 expression by human keratinocytes by UVB (2000) (21)
- Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma (1982) (21)
- Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect (2004) (20)
- T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles. (2013) (20)
- Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy. (1999) (20)
- Regulation of Immature Protein Dynamics in the Endoplasmic Reticulum* (2004) (19)
- Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S-cysteaminylphenol in black and yellow hair follicles. (1995) (19)
- Scar and keloidlike lesions in progeria. An electron-microscopic and immunohistochemical study. (1988) (19)
- Reactivity of orthoquinones involved in tyrosinase‐dependent cytotoxicity: differences between alkylthio‐ and alkoxy‐substituents (1992) (19)
- Localized Lymphomatoid Papulosis (2002) (18)
- Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues. (1983) (18)
- Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells. (2018) (18)
- Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma. (1989) (17)
- A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes. (1993) (17)
- Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three‐dimensional magnetic cell culture array (2013) (17)
- Induction of apoptosis in melanoma cell lines by p53 and its related proteins. (2001) (17)
- 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase. (1990) (17)
- Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis. (1999) (17)
- A computed image analyzing system for quantitation of melanocyte morphology in café-au-lait macules of neurofibromatosis. (1987) (16)
- Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. (1987) (16)
- Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma. (1989) (16)
- Immunohistochemical Localization of Activated EGF Receptor in Human Eccrine and Apocrine Sweat Glands (2001) (16)
- The in vivo melanocytotoxicity and depigmenting potency of N‐2,4‐acetoxyphenyl thioethyl acetamide in the skin and hair (1995) (16)
- N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model. (2012) (16)
- Identification of a cDNA coding for a Ca(2+)-binding phosphoprotein (p90), calnexin, on melanosomes in normal and malignant human melanocytes. (1993) (16)
- UVB Photosensitivity due to Ranitidine (2000) (15)
- Successful Treatment of a Patient with Lymphomatoid Papulosis by Methotrexate (2001) (15)
- The real-time, three-dimensional analyses of benign and malignant skin tumors by confocal laser scanning microscopy. (2006) (14)
- Conjugation of Magnetite Nanoparticles with Melanogenesis Substrate, NPrCAP Provides Melanoma Targeted, in Situ Peptide Vaccine Immunotherapy through HSP Production by Chemo-Thermotherapy (2012) (14)
- Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs. (1994) (14)
- Epidermodysplasia verruciformis associated with Bowen's carcinoma, B lymphocytopenia and decreased immune functions. (1985) (14)
- Expression of gamma‐glutamyl transpeptidase in normal and neoplastic epithelial cells of human skin: a marker for distinguishing malignant epithelial tumours (1986) (14)
- Rab7 is a critical mediator in vesicular transport of tyrosinase‐related protein 1 in melanocytes (2011) (14)
- Cutaneous T‐Cell Lymphoma and Related Disorders (1986) (14)
- Dysplastic Melanocytic Nevus Electron‐Microscopic Observation as a Diagnostic Tool (1987) (14)
- Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models. (2012) (14)
- "Total" acidic metabolites of catecholamines in urine as determined by hydrolysis with hydriodic acid and liquid chromatography: application to patients with neuroblastoma and melanoma. (1985) (13)
- Selective cytotoxicity of N‐acetyl‐4‐S‐cysteaminylphenol on follicular melanocytes of black mice (1991) (13)
- Small cell variant of CD30+ primary cutaneous T‐cell lymphoma with epidermotropism that completely regressed after incisional skin biopsy (2006) (13)
- Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction. (2003) (13)
- The role of phosphoinositide 3-kinase in the sorting and transport of newly synthesized tyrosinase-related protein-1 (TRP-1). (2001) (13)
- Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2. (1988) (12)
- [Evaluation of rIFN-gamma in the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration]. (1987) (12)
- Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles (2013) (12)
- Wells' syndrome: vesiculobullous presentation and possible role of ectoparasites (1997) (11)
- Multiple pigmented follicular cysts: a subtype of multiple pilosebaceous cysts (1996) (11)
- Tyrosinase transfection produces melanin synthesis and growth retardation in glioma cells (1998) (11)
- Fulminant bowel‐associated dermatosis‐arthritis syndrome that clinically showed necrotizing fasciitis‐like severe skin and systemic manifestations (2006) (10)
- Divalent cations control cell-substrate adhesion and laminin expression in normal and malignant human melanocytes in early and late stages of cellular differentiation. (1995) (9)
- Inhibition of CD62L+ T-cell response in vitro via a novel sulfo-glycolipid, beta-SQAG9 liposome that binds to CD62L molecule on the cell surface. (2004) (9)
- Ultrasonic measurement of melanosomes for characterization of their physicochemical structure in B16 and Harding-Passey melanomas. (1984) (9)
- Lymphoid Proliferation and Lymphoma Associated with Human Retroviruses (HTLV and HIV) (1991) (9)
- Dominant oculo‐cutaneous albinism (1974) (9)
- IMMUNOHISTOCHEMICAL AND ELECTRON MICROSCOPIC CHARACTERIZATION OF LYMPHOMATOID PAPULOSIS (1978) (9)
- CHEMOIMMUNOTHERAPY FOR DISSEMINATED MALIGNANT MELANOMA WITH DTIC, ACNU, VCR AND OK432 (1982) (8)
- Distribution and organelle specificity of melanoma‐associated antigens identified by Mo 465.12 in human malignant melanoma (1985) (8)
- Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution. (1988) (8)
- Dual surface makers and HTLV‐I proviral DNA in a cutaneous tumour nodule in a case of adult T cell leukaemia/lymphoma (1987) (8)
- Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells. (1989) (8)
- Detection of human papillomavirus type 16 in bowenoid papulosis and nonbowenoid tissues (2003) (8)
- Characterization of melanosome‐associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti‐melanosome antibody (1993) (8)
- Characterization of surface markers and cytoplasmic organelle in benign and malignant lymphoid lesions of skin; Immunohistochemical and electron microscopic evaluation (1981) (8)
- Three-dimensional magnetic cell array for evaluation of anti-proliferative effects of chemo-thermo treatment on cancer spheroids (2015) (8)
- Biological Role of Tyrosinase‐Related Protein and Its Relevance to Pigmentary Disorders (Vitiligo Vulgaris) (1999) (8)
- Immunohistochemical Characterization of Spitz's Nevus: Differentiation from Common Melanocytic Nevus, Dysplastic Melanocytic Nevus and Malignant Melanoma (1987) (8)
- Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol. (1975) (7)
- Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma (1988) (7)
- Polyethylene-glycol-mediated delivery of liposome-entrapped pigments into fibroblasts: experimental pigment cells as models for mutator phenotypes. (1992) (7)
- Papulonecrotic tuberculid‐like eruptions after Bacille Calmette‐Guerin vaccination (2007) (7)
- Lysosomal Degradation of Melanosome (1971) (7)
- [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma]. (1984) (7)
- Acute graft-vs-host disease in an immunodeficient newborn possibly due to cytomegalovirus infection. (1989) (7)
- Development and characterization of a murine monoclonal antibody against phaeomelanin and its precursor 5‐S‐cysteinyldopa (1993) (7)
- Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein (1992) (7)
- Ectopic expression of tyrosinase increases melanin synthesis and cell death following UVB irradiation in fibroblasts from familial atypical multiple mole and melanoma (FAMMM) patients (2004) (7)
- A Case of Systemic Osteomyelitides Due to Mycobacterium avium (2004) (6)
- Cytogenetics of Melanocytic Tumors. (1993) (6)
- Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas. (1983) (6)
- [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway]. (1998) (6)
- TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD). (2014) (6)
- cDNA-based functional domains of a calnexin-like melanosomal protein, p90. (1993) (6)
- Development of MoAb HMSA-3 and HMSA-4 against human melanoma melanosomes and their reactivities on formalin-fixed melanoma tissues. (1987) (6)
- Nature and biosynthesis of structural matrix protein in melanosomes: melanosomal structural protein as differentiation antigen for neoplastic melanocytes. (1988) (5)
- Lower Lip and Vermilion Reconstruction with Buccal Musculomucosal Flap Combined with V-Y Plasty after Malignant Tumor Excision (2006) (5)
- Dextromethorphan induces multifocal fixed drug eruption. (2003) (5)
- Application of MoAb HMSA-2 for immunohistopathologic diagnosis of amelanotic and/or regressed lesions of human melanoma on routine paraffin sections (1986) (5)
- Clear reticulated cytoplasm of human eccrine sweat glands: immunohistochemical differentiation from pathological degeneration (2005) (5)
- Dysplastic Melanocytic Nevus Immunohistochemical Heterogeneity by Melanosomal Markers and S‐100 (1991) (5)
- Ultrastructural Observations on DMBA-Induced Dermal Hyperpigmentation and Blue Nevus-Like Tumors in the Mongolian Gerbil 1 (1980) (5)
- Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review (2022) (5)
- Melanogenesis Exploitation and Melanoma Nanomedecine: Utilization of Melanogenesis Substrate, NPrCAP for Exploiting Melanoma-Targeting Drug and its Conjugation with Magnetite Nanoparticles for Developing Melanoma Chemo-Thermo-Immunotherapy (2011) (4)
- Kimura's Disease: Immunohistochemistry of Infiltrating Cells Using Monoclonal and Polyclonal Antibodies (1986) (4)
- Synthesis and radioiodination of 3‐(E)‐(2‐iodovinyl)‐N‐acetyl‐4‐cysteaminylphenol, a putative tyrosinase substrate for imaging neural crest tumours (1998) (4)
- Spontaneous regression of bowenoid papulosis in a patient with acquired immunodeficiency syndrome after an increase in peripheral CD4+ T lymphocytes (2009) (4)
- [A huge subcutaneous tumor occurring on the face (malignant eccrine spiradenoma)--histochemical and electron microscopy study]. (1987) (4)
- Photodynamic action of ultraviolet A: induction of cellular hydroperoxides. (1995) (4)
- Both of the N-terminal and C-terminal regions of human papillomavirus type 16 E7 are essential for immortalization of primary rat cells. (2001) (3)
- A Case of Neuro‐cutaneous Melanosis (1970) (3)
- The synthesis of N-acetyl-4-S-cysteaminyl [U-14C]phenol as a basis for the development of an antimelanoma and melanoma-radioimaging agent. (1994) (3)
- Increased caspase-2 activity is associated with induction of apoptosis in IFN-beta sensitive melanoma cell lines. (2010) (3)
- EPIDERMODYSPLASIA VERRUCIFORMIS (1985) (3)
- The synthesis of 4-S-cysteinyl-[U-14C]phenol, an experimental antimelanoma agent. (1989) (3)
- A Case of Nevoid Basal Cell Carcinoma Syndrome. (2002) (3)
- Erratum to “Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells” [Exp. Cell Res. 298 (2004) 317–328] (2004) (2)
- Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development (2022) (2)
- Reconstruction method with a newly-designed bilobed flap after excision of tumours of the skin (2006) (2)
- Testicular swelling as the presenting sign of cutaneous malignant melanoma (2006) (2)
- Analysis of Human Melanosome-Specific Antigen in Malignant Melanoma and Its Precursors (1990) (2)
- CHEMOIMMUNOTHERAPY FOR MELANOMA WITH DTIC, ACNU, VCR AND OK432 (1981) (2)
- Immunochemical characterization of murine B16 melanoma-associated antigens and their detection in sera of tumor-bearing hosts by radioimmunoassay. (1981) (2)
- Correspondence (2003) (2)
- CYTOMORPHOGENESIS AND MELANOSOME TRANSFER DURING MALIGNANT TRANSFORMATION IN MELANOCYTES AND MELANOMA CELLS (1979) (2)
- Localization and Characterization of Anionic Sites in Extramammary Paget's Disease with Cationic Colloidal Gold (1999) (2)
- A melanosome-associated monoclonal antibody J1 recognizes luminal membrane of prelysosomes common to biogenesis of melanosomes and lysosomes. (2001) (2)
- [Fine structure of mitotic melanocytes in the epidermis of C57 black mouse after UV irradiation (UV-A) (author's transl)]. (1977) (2)
- E-rosette inhibitory factor in sera from patients with mycosis fungoides. (1981) (2)
- CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy (2007) (1)
- [Epidermotropically metastatic malignant melanoma: differentiation from primary melanoma]. (1982) (1)
- [A case of suppressor/cytotoxic T cell lymphoma originating from the skin and revealing a rapid clinical course due to DIC]. (1984) (1)
- [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis]. (1984) (1)
- N-PROPIONYL-4-S-CYSTEAMINYLPHENO EXERTS SELECTIVE MELANOCYTOTOXICITY THROUGH APOPTOTIC PROCESS (1998) (1)
- Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumours (2005) (1)
- [Surface marker and clinical diversity in cutaneous T cell lymphoma (CTCL): a case showing spontaneous regression and double marker]. (1987) (1)
- Successful scintigraphic visualization of metastatic lesions of a hard palate melanoma with N‐isopropyl‐p‐[123I]‐iodoamphetamine (2003) (1)
- International diploma course in dermatology (1996) (1)
- [Werner's syndrome associated with malignant melanoma (author's transl)]. (1980) (1)
- [A case of CTCL (TH/I) with tubulo-reticular structure in tumor cells and spontaneous regression]. (1985) (1)
- Pyoderma Chronica Occurring on Both Lower Legs (2003) (1)
- [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin]. (1984) (1)
- Interaction of calnexin and calreticulin is required for acid-resistant structure and correct processing of tyrosinase-related protein from ER to melanosomes (1998) (1)
- [Topical application of ACNU for the treatment of mycosis fungoides]. (1982) (1)
- Ultrasonic comparison of two morphologically distinct melanosomes in malignant melanomas (1984) (1)
- [Electron microscopic study of melanocytes and melanosomes of human inner ear]. (1986) (1)
- Modification of Wound Healing Process Using Basic Fibroblast Growth Factor (2005) (1)
- Exploitation of melanin and melanosome biogenesis for better management of malignant melanoma (2005) (0)
- Signaling Pathway Contributes to Inhibition of the Interferon 1 Signaling-3 by Herpes Simplex Virus Type Induction of Suppressor of Cytokine (2003) (0)
- The role of phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized TRP-1 melanoma cells: Implications in the biogenesis of melanosomes (1998) (0)
- 141 Analysis of chaperone function of calnexin in folding of melanosomal membrane proteins (1997) (0)
- P22 A case report of the use of tetracycline in bullous pemphigoid (1996) (0)
- Report on United States--Japan Cooperative Cancer Research Program: melanoma and skin cancer--biology and comparative features in the United States and Japan. (1989) (0)
- Exploitation of metabolic pathway specific to melanoma cells for the development of targeted chemotherapy: 138 (1997) (0)
- Development and Characterization of a Mouse Monoclonal Antibody , MoAb HMSA 4 , against a Melanosomal Fraction of Human Malignant Melanoma ' (2006) (0)
- P24 Expression of metastasis suppressor gene product, NM23 protein, is not correlated with the metastasis of human malignant melanoma (1996) (0)
- 正常ヒト表皮メラノサイト(NHEM)とヒト異色腫細胞株SK-MEL23の細胞増殖と分化に対する線維芽細胞培養液上清(FCM)の影響 (1997) (0)
- P12 Dermal matrix for the establishment of reconstituted epidermal melanin unit (EMU) (1996) (0)
- Induction of cell death in melanoma cells by magnetite-conjugated N-propionyl cysteaminylphenol (NPrCAP/M) nanoparticles (2006) (0)
- P7 The role of calnexin in folding and maturation of tyrosinase: Major protein of melanogenesis (1996) (0)
- Involvement of rab 7 and phosphatidyl inosidtol 3-kinase for vesicular transport of TRP-1 between TGN and melanosome (1998) (0)
- [Establishment of image analyzing system for evaluation of melanocyte morphology]. (1985) (0)
- RADIOCHEMOTHERAPY USNG PHENOLC THOETERAMINES AND ACYL (2017) (0)
- Pre- and post-translational expression of UV-induced melanogenesis in melanoma cells (1993) (0)
- [Elucidation of melanogenesis and its application to clinical diagnosis and treatment]. (1985) (0)
- Detection of Varicella-Zoster Virus Nucleic Acids in Peripheral Lymphocytes from Patients with Herpes Zoster (2007) (0)
- [Lentigo maligna melanoma and nodular melanoma occurring on face: case presentation and statistical analysis]. (1987) (0)
- A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma (2023) (0)
- Development of novel NPrCAP-magnetite nanoparticles and evaluation of the therapeutic effect by chemo-thermo-immunotherapy for melanoma (2013) (0)
- Tyrosinase-mediated cytocidal effect on melanocytes and melanoma cells by a pseudo-melanin precursor, N-propionyl-4-S-cysteaminylphenol (1998) (0)
- Establishment of a computed image analyzing system for quantitative characterization of melanocytes in café-au lait macules of neurofibromatosis patients (1986) (0)
- 28 Characterization of a melanosomal G-protein from mouse melanoma in the transportation of TRP-1 (1996) (0)
- Cellular basis for the specific antimelanoma action of N-propionyl-4-S-cysteaminyl phenol (1998) (0)
- Basic fibroblast growth factor administration reduces scar formation in acute incisional wounds (2003) (0)
- Dna microarray analyses of japanese melanomas and expression of cyclin d1 as a molecular prognostic marker. (2004) (0)
- [Skin infiltration of extranodal non-Hodgkin's lymphoma: 2 cases having the original loci at the skin and Waldeyer's ring]. (1982) (0)
- The influence of melanin formation, either by inhibiting tyrosinase activity or by saturating melanin binding sites, as well as the addition of synthetic melanin, confirmed this scavenging effect. Additionally the N-(2-dialkylami- noethyl)benzamide structure element is responsible for higher DNA aff (2006) (0)
- Basic Fibroblast Growth Factor Accelerates Apoptosis in Acute Incisional Wound Healing and Reduces Scar Formation (2005) (0)
- Abstracts of the Conjoint Meeting of XXth International Pigment Cell Conference & Vth International Melanoma Research Congress (2017) (0)
- P 147 N-Propionyl-4S-Cysteaminylphenol generates reactive oxygen species and mediates apoptosis in pigmented melanoma cells (2017) (0)
- A Nodular Melanoma of the Mid-back Occuring in a Young Male Adult. A Statistical Analysis of 113 Cases of Malignant Melanoma over the Last 10 Years at the Department of Dermatology, Sapporo Medical University. (2001) (0)
- Characterization of biological and biochemical properties of melanosomal protein in human malignant melanoma by development of monoclonal antibody, MoAb HMSA-1 (1986) (0)
- XII International Pigment Cell Conference: Part II (1984) (0)
- [Clinical, histopathological and ultrastructural characteristics of dysplastic melanocytic nevus in comparison to cutaneous malignant melanoma--II: Ultrastructural characteristics of melanocytes and melanosomes]. (1985) (0)
- [Dysplastic nevus: I: Clinical and histological findings]. (1984) (0)
- P18 The clinical heterogeneity of lymphomatoid papulosis (1996) (0)
- 15 Extramammary Paget's disease expresses anionic sites characteristic to apocrine sweat gland (1996) (0)
- [A case of cutaneous lymphoid hyperylasia with subcutaneous induration and infitration into musle; histological and electron microscopical characterization of infiltrating cells (author's transl)]. (1979) (0)
- 顔面に発生する悪性黒子型，結節型黒色腫―症例の供覧と統計― (1987) (0)
- [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)]. (1978) (0)
- SEZARY'S SYNDROME: A CASE REPORT INCLUDING ULTRASTRUCTURAL AND IMMUNOHISTO‐CHEMICAL CHARACTERIZATION OF THE CELLULAR INFILTRATES (1981) (0)
- Induction of lipid hydroperoxides in cultured human fibroblasts by UVA (1993) (0)
- Tyrosinase mediated selective accumulation and antitumor effect of a sulfur homologue of phenol and its amine derivative in melanoma (1988) (0)
- UVA may inhibit UV-induced immunosupression by upregulation of IL-12 in human keratinocytes (1998) (0)
- N-propionyl-4-S-cysteaminylphenolのアポトーシスを介した色素細胞障害効果 (1998) (0)
- Effect of Topical Capsaicin on Pain and Itch in Various Dermatologic Diseases. (2001) (0)
- APE/Ref-1 deficiency inhibits cellular transformation and metastatic potential of human melanoma cells (2017) (0)
- [Clinical and prognostic specificity of anorectal malignant melanoma]. (1983) (0)
- 017 Localization of activated form of EGF-receptor in human eccrine and apocrine sweat glands (1997) (0)
- [A case of multiple malignant schwannoma showing remission with chemoimmunotherapy. (author's transl)]. (1980) (0)
- [Pigmented storiform neurofibroma occurring in a girl: electron microscopic characterization of proliferating cells and dermal melanocytes]. (1985) (0)
- 3 Expression of human tyrosinase in rat glioma cells as a chemotherapy model using antimelanoma drugs (1996) (0)
- [Subungual amelanotic superficial spreading melanoma: a case diagnosed with mouse monoclonal antibodies against human melanosome-associated antigens (HMSA)]. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kowichi Jimbow?
Kowichi Jimbow is affiliated with the following schools:
